Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kodiak SciencesMEX:KOD 27 Market Cap is MXN45,058.67 Mil as of Jul. 14, 2026. GuruFocus rates MEX:KOD with a GF Score™ of 27/100. The stock has 4 warning signs investors should review. Among 1,423 Biotechnology companies, Kodiak Sciences ranks better than 90.58% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Kodiak Sciences's share price for the quarter that ended in Mar. 2026 was MXN428. Kodiak Sciences's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 62.16 Mil. Therefore, Kodiak Sciences's market cap for the quarter that ended in Mar. 2026 was MXN26,602.77 Mil.
Kodiak Sciences's quarterly market cap
increased
from Sep. 2025 (MXN2,702.95 Mil) to Dec. 2025 (MXN26,432.42 Mil) and
increased
from Dec. 2025 (MXN26,432.42 Mil) to Mar. 2026 (MXN26,602.77 Mil).
Kodiak Sciences's annual market cap
declined
from Dec. 2023 (MXN8,441.35 Mil) to Dec. 2024 (MXN7,698.14 Mil) but then
increased
from Dec. 2024 (MXN7,698.14 Mil) to Dec. 2025 (MXN26,432.42 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kodiak Sciences's Enterprise Value for Today is MXN43,069.59 Mil.
Kodiak Sciences (MEX:KOD) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Kodiak Sciences Market Cap Related Terms
Kodiak Sciences Market Cap Historical Data
* Premium members only.
The historical data trend for Kodiak Sciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:KOD vs ABCL, AGIO, IMNM: Market Cap Comparison
For the Biotechnology subindustry, Kodiak Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kodiak Sciences Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kodiak Sciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Kodiak Sciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Kodiak Sciences's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kodiak Sciences (MEX:KOD) has a Market Cap of MXN45,058.67 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kodiak Sciences and its competitors. According to the industry distribution chart, Kodiak Sciences ranks #134 out of 1423 companies in the Biotechnology industry, placing it in the top 9.4%.
Is Kodiak Sciences' Market Cap too high?
Kodiak Sciences' current Market Cap is MXN45,058.67 Mil. Based on the distribution chart, Kodiak Sciences ranks #134 out of 1423 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Kodiak Sciences has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Kodiak Sciences' Market Cap compare to ABCL and AGIO?
According to the Biotechnology industry distribution chart, Kodiak Sciences ranks #134 out of 1423 companies for Market Cap. This places Kodiak Sciences in the top 9% of its industry — outperforming the majority of peers. The industry median Market Cap is 115.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 115.88, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kodiak Sciences and its competitors. For the Biotechnology industry, the median Market Cap is 115.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kodiak Sciences's current Market Cap is MXN45,058.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kodiak Sciences stock overvalued right now?
Kodiak Sciences (MEX:KOD) has a current Market Cap of MXN45,058.67 Mil. The current Market Cap is MXN45,058.67 Mil. Kodiak Sciences' overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Kodiak Sciences (MEX:KOD), the current Market Cap is MXN45,058.67 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.
27GF Score
Get the complete analysis for MEX:KOD
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:KOD has been successfully added to your 
